TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Trulieve Cannabis Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$10.28+0.27 (+2.70%)
Close on Oct 19, 2026
- Market cap
- $1.98B
- P/E (TTM)
- –
- Dividend yield
- –
Trulieve Cannabis Corp. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Retail | $1.11B | $1.13B | $1.08B | $1.16B | $869.71M | $520.22M | 94.0% | -1.6% |
| Wholesale and other | $70.74M | $57.61M | $45.65M | $59.75M | – | – | 6.0% | +22.8% |
| Wholesale, Licensing and Other | – | – | – | $78.13M | $67.88M | $1.32M | – | – |
| Licensing and Other | – | – | $2.26M | $4.67M | $1.09M | – | – | – |
| Wholesale and other | – | – | $43.39M | $55.09M | $61.14M | – | – | – |
By region
From the segment and revenue-disaggregation notes of Trulieve Cannabis's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.